Quantum Biopharma (QNTM) Capital Expenditures (2022)
Quantum Biopharma recorded quarterly Capital Expenditures of $230839.0 in Q4 2022, up 338.18% quarter-over-quarter from -$96917.0 in Q3 2022.
Quantum Biopharma's Capital Expenditures history runs 1 years deep, the most recent figure standing at $230839.0 for Q4 2022.
- In Q4 2022, Capital Expenditures changed N/A year-over-year to $230839.0; the TTM figure through Dec 2022 stood at $113958.0 (changed N/A YoY), while the FY2022 annual figure was $113958.0, changed N/A from the prior year.
- Capital Expenditures came in at $230839.0 for Q4 2022 at Quantum Biopharma, up from -$96917.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $230839.0 in Q4 2022 to a low of -$96917.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 786,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 230,839.00 |
| Dec 31, 2022 | 230,839.00 |
| Sep 30, 2022 | -96,917.00 |
| Sep 30, 2022 | -96,917.00 |
| Jun 30, 2022 | -5,342.00 |
| Jun 30, 2022 | -5,342.00 |
| Mar 31, 2022 | -14,622.00 |
| Mar 31, 2022 | -14,622.00 |